January 19, 2024
Virginia Catalyst Announces Grant Round 15 Awarded Projects
The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it has awarded $2.2…
January 19, 2024
BioHealth Innovation, Inc.’s Rich Bendis Named Finalist for the Community Builder Award in the 2023 BioHealth Capital Region Annual Awards
Rockville, MD – BioHealth Innovation, Inc. (BHI) is proud to announce that our Founder, President & CEO, Rich Bendis, has…
January 17, 2024
Luminoah’s Receives $463,000 Grant from Virginia Catalyst
CHARLOTTESVILLE, VA – January 11, 2024 – Luminoah Inc., a medical technology company dedicated to improving the standard of care for…
January 16, 2024
REGENXBIO Announces Positive Interim Data from Phase II AAVIATE® Trial of ABBV-RGX-314 for the Treatment of Wet AMD Using Suprachoroidal Delivery
ROCKVILLE, Md., Jan. 16, 2024 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced positive interim data from the Phase II…
January 16, 2024
BioHealth Innovation, Inc. (BHI) Welcomes Peter Ronco as a New Member of the Board of Directors
ROCKVILLE, MARYLAND, January 16, 2024– BioHealth Innovation, Inc. (BHI), a leading public-private non-profit organization dedicated to advancing healthcare innovation in…
January 16, 2024
Children’s National Novel AI platform matches cardiologists in detecting rheumatic heart disease
WASHINGTON, D.C., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Artificial intelligence (AI) has the potential to detect rheumatic heart disease (RHD)…
January 16, 2024
Precigen Receives Orphan Drug Designation for PRGN-2012 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission
GERMANTOWN, Md., Jan. 16, 2024 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative…